Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection

Infection

Volumn 24, Issue 4, 1996, Pages 301-308

  Weiss, M ^a   Martignoni, M ^a   Petropoulou, T ^a   Solder B ^a   Belohradsky, B H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE ACTIVATION; MONOCYTE; PROTEIN DEGRADATION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0029783799     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01743365     Document Type: Article

References (52)

1. Stein, D. S., Korvick, J. A., Vermund, S. H.: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus disease: a review. J. Infect. Dis. 165 (1992) 352-363.
2. Roux-Lombard, P., Modoux, C., Cruchaud, A., Dayer, J.-M.: Purified blood monocytes from HIV-1-infected patients produce high levels of TNF-α and IL-1. Clin. Immunol. Immunopathol. 50 (1989) 374-384.
3. Fauci, A. S.: The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239 (1988) 617-622.
4. Matsuyama, T., Kobayashi, N., Yamamoto, N.: Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 5 (1991) 1405-1417.
5. Michihiko, S., Yamamoto, N., Shinozaki, F., Shimada, K., Soma, G.-I., Kobayashi, N.: Augmentation of in-vitro HIV replication in peripheral blood mononuclear cells of AIDS and ARC patients by tumor necrosis factor. Lancet i (1989) 1206-1207.
6. Folks, T. M., Clouse, K. A., Justement, J., Rabson, S., Duh, E., Kehrl, J. H., Fauci, A. S.: Tumor necrosis factor a induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86 (1989) 2365-2368.
7. Kitano, K., Rivas, C., Baldwin, G. C., Vera, J. C., Golde, D. W.: Tumor necrosis factor-dependent proliferation of human immunodeficiency virus 1 in chronically infected HL-60 cells. Blood 82 (1993) 2742-2748.
8. Beutler, B., Cerami, A.: Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu. Rev. Biochem. 57 (1988) 505-518.
9. Vilcek, J., Lee, T. H.: Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266 (1991) 7313-7316.
10. Ibelgaufts, H.: Lexikon Zytokine. Medikon-Verlag, München 1992.
11. Callard, R. E., Gearing, A. J. H.: TNFα. The molecule and the TNF receptors. In: The cytokine facts book. Academic Press, Harcourt Brace & Company, London 1994, pp. 241-246.
12. Tartaglia, L. A., Goeddel, D. V.: Two TNF receptors. Immunol. Today 13 (1992) 151-153.
13. Dembic, Z., Loetscher, H., Gubler, U., Pan, Y.-C. E., Lahm, H.-W., Gentz, R., Brockhaus, M., Lesslauer, W.: Two types of human TNF receptors have similar extracellular domain, but distinct intracellular domain sequences. Cytokine 2 (1990) 231-237.
14. Brockhaus, M., Schoenfeld, H. J., Hunziker, W., Lesslauer, W., Loetscher, H.: Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87 (1990) 3127-3131.
15. Nophar, Y., Kemper, O., Brakebusch, C., Engelmann, H., Zwang, R., Aderka, D., Holtmann, H., Wallach, D.: Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type 1 TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and the soluble form of the receptor. EMBO J. 9 (1990) 3269-3278.
16. Engelmann, H., Novick, D., Wallach, D.: Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J. Biol. Chem. 265 (1990) 1531-1536.
17. Lantz, M., Gullberg, U., Nilsson, E., Olsson, I.: Characterization in vitro of a human tumor necrosis factor-binding protein: a soluble form of a tumor necrosis factor receptor. J. Clin. Invest. 86 (1990) 1196-1202.
18. Kohno, T., Brewer, M. T., Baker, S. L., Schwartz, P. E., King, M. W., Hale, K. K., Squires, C. H., Thompson, R. C., Vannice, J. L.: A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA 87 (1990) 8331-8335.
19. Hwang, C., Gatanaga, M., Granger, G., Gatanaga, T.: Mechanism of release of soluble forms of tumor necrosis factor/lymphotoxin receptors by phorbol myristate acetate-stimulated human THP-1 cells in vitro. J. Immunol. 151 (1993) 5631-5638.
20. Bjornberg, F., Lantz, M., Olsson, I., Gullberg, U.: Mechanisms involved in the processing of the p55 and the p75 tumor necrosis factor (TNF) receptors to soluble receptor forms. Lymphokine Cytokine Res. 13 (1994) 203-211.
21. Lantz, M., Malik, S., Slevin, M. L., Olsson, I.: Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine 2 (1990) 402-406.
22. van Zee, K. J., Kohno, T., Fischer, E., Rock, C. S., Moldawer, L. L., Lowry, S. F.: Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α; in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89 (1992) 4845-4849.
23. Spinas, G. A., Keller, U., Brockhaus, M.: Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J. Clin. Invest. 90 (1992) 533-536.
24. Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C., Wallach, D.: Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 175 (1992) 323-329.
25. Aderka, D., Engelmann, H., Hornik, V., Skornick, Y., Levo, Y., Wallach, D., Kushtai, G.: Increased serum levels of soluble receptors for tumor necrosis factor in cancer. Cancer Res. 51 (1991) 5602-5607.
26. Waage, A., Liabakk, N.-B., Lien, E., Lamvik, J., Espevik, T.: p55 and p75 tumor necrosis factor receptors in patients with chronic lymphocytic leukemia. Blood 80 (1992) 2577-2583.
27. Kern, W. V., Engel, A., Kern, P.: Soluble tumor necrosis factor receptors in febrile neutropenic cancer patients. Infection 23 (1995) 64-65.
28. Heilig, B., Wermann, M., Gallati, H., Brockhaus, M., Berke, B., Egen, O., Pezzutto, A., Hunstein, W.: Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis. Clin. Invest. 70 (1992) 22-27.
29. Heilig, B., Fiehn, C., Brockhaus, M., Gallati, H., Pezzutto, A., Hunstein, W.: Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease. J. Clin. Immunol. 13 (1993) 321-327.
30. Arnold, J. C., Heilig, B., Kallinowski, B., Otto, G., Kommerell, B., Theilmann, L.: Soluble tumor necrosis factor receptors in patients with recurrent hepatitis C infection after liver transplantation. Clin. Invest. 72 (1994) 470.
31. Halwachs, G., Tiran, A., Reisinger, E. C., Zach, R., Sabin, K., Fölsth, B., Lanzer, H., Holzer, H., Wilders-Truschnig, M.: Serum levels of the soluble receptor for tumor necrosis factor in patients with renal disease. Clin. Invest. 72 (1994) 473-476.
32. Girardin, E., Roux-Lombard, P., Grau, G. E., Suter, P., Gallati, H., Dayer, J.-M.: Imbalance between tumor necrosis factor-α and soluble TNF receptor concentration in severe meningococcaemia. The J5 Study Group. Immunology 76 (1992) 20-23.
33. Kern, P., Hemmer, C. J., Gallati, H., Neifer, S. N., Kremsner, P., Dietrich, D., Porzsolt, F.: Increased serum levels of soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J. Infect. Dis. 166 (1992) 930-934.
34. van der Poll, T., Jansen, J., van Leenen, D., von der Möhlen, M., Levi, M., ten Cate, H., Gallati, H., ten Cate, J. W., van Deventer, S. J. H.: Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J. Infect. Dis. 168 (1993) 955-960.
35. Kalinkovich, A., Engelmann, H., Harpaz, N., Burstein, R., Barak, V., Kalickman, I., Wallach, D., Bentwich, Z.: Elevated serum levels of soluble tumor necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin. Exp. Immunol. 89 (1992) 351-355.
36. + lymphocytes. Clin. Exp. Immunol. 93 (1993) 350-355.
37. Aukrust, P., Liabakk, N.-B., Müller, F., Lien, E., Espevik, T., Frøland, S. S.: Serum levels of tumor necrosis factor-α (TNFα) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic and virologic parameters. J. Infect. Dis. 169 (1994) 420-424.
38. Aukrust, P., Liabakk, N.-B., Müller, F., Espevik, T., Frøland, S. S.: Activation of tumor necrosis factor-α system in HIV-1 infection: association with markers of immune activation. Infection 23 (1995) 9-15.
39. Zangerle, R., Gallati, H., Sarcletti, M., Weiss, G., Denz, H., Wachter, H., Fuchs, D.: Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation. J. Acquir. Immune Defic. Syndr. 7 (1994) 79-85.
40. Godfried, M. H., van der Poll, T., Jansen, J., Romijin, J. A., Schattenkerk, J. K. M. E., Endert, E., van Deventer, S. J. H., Sauerwein, H. P.: Soluble receptors for tumor necrosis factor: a putative marker of disease progression in HIV infection. AIDS 7 (1993) 33-36.
41. Godfried, M. H., van der Poll, T., Weverling, G. J., Mulder, J. W., Jansen, J., van Deventer, S. J. H., Sauerwein, H. P.: Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J. Infect. Dis. 169 (1994) 739-745.
42. Heaney, M. L., Golde, D. W.: Soluble cytokine receptors. Blood 87 (1996) 847-857.
43. Centers for Disease Control and Prevention: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41 (No. RR-17) (1992) 1-19.
44. Centers for Disease Control and Prevention: 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 43 (No. RR-12) (1994) 1-10.
45. The European Collaborative Study: Age-related standards for T lymphocyte subsets based on uninfected children born to human immunodeficiency virus 1-infected women. Pediatr. Infect. Dis. J. 11 (1992) 1018-1026.
46. + lymphocyte parameters in healthy children at risk for infection with the human immunodeficiency virus. Clin. Infect. Dis. 17 (1993) 123-125.
47. McKinney, R. E., Wilfert, C. M.: Lymphocyte subsets in children younger than 2 years old: normal values in a population at risk for human immunodeficiency virus infection and diagnostic and prognostic application to infected children. Pediatr. Infect. Dis. J. 11 (1992) 639-644.
48. Leeuwenberg, J. E. M., Dentener, M. A., Buurman, W. A.: Lipopolysaccharide (LPS)-mediated soluble TNF receptor release and TNF receptor expression by monocytes. J. Immunol. 152 (1994) 5070-5076.
49. Porteu, F., Hieblot, C.: Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. J. Biol. Chem. 269 (1994) 2834-2840.
50. Honda, M., Kitaniura, K., Matsuda, K., Yokota, Y., Yamamoto, N., Mitsuyasu, R., Chermann, J.-C., Tokunaga, T.: Soluble IL-2 receptor in AIDS. Correlation of its serum level with the classification of HIV-induced diseases and its characterization. J. Immunol. 142 (1989) 4248-4255.
51. Scott-Algara, D., Vuillier, F., Marasescu, M., de Saint Martin, J., Dighiero, G.: Serum levels of IL-2. IL-1α. TNF-α, and soluble receptor of 1L-2 in HIV-1-infected patients. AIDS Res. Hum. Retroviruses 7 (1991) 381-386.
52. Bilello, J. A., Stellrecht, K., Drusano, G. L., Stein, D. S.: Soluble tumor necrosis factor-α receptor type II (sTNFαRII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients. J. Infect. Dis. 173 (1996) 464-467.